Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.09% |
| 2 | Healthcare | 16.64% |
| 3 | Technology | 14.97% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Tempest Therapeutics
TPST
$14.8M
| $16.1M | 0.02% |
1,055
-1
| -0.1% | -$22.8K |
|
427
CALL
Incyte
INCY
$23.5B
| $16M | 0.02% |
200,000
| – | – |
|
428
Artisan Partners
APAM
$2.79B
| $16M | 0.02% |
577,529
-62,828
| -10% | -$1.98M |
|
429
Wingstop
WING
$3.68B
| $15.8M | 0.02% |
+580,843
| New | +$15.1M |
|
|
MYCC
430
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $15.8M | 0.02% |
1,214,671
-8,574
| -0.7% | -$109K |
|
431
Steel Dynamics
STLD
$35.6B
| $15.8M | 0.02% |
+643,408
| New | +$15.7M |
|
|
DWRE
432
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $15.2M | 0.02% |
202,828
-195,622
| -49% | -$10.6M |
|
|
MDVN
433
CALL
DELISTED
MEDIVATION, INC.
MDVN
| $15.1M | 0.02% |
+250,000
| New | +$14.2M |
|
434
Shake Shack
SHAK
$2.3B
| $15M | 0.02% |
412,503
-19,141
| -4% | -$695K |
|
|
TEP
435
DELISTED
Tallgrass Energy Partners, LP
TEP
| $15M | 0.02% |
326,338
-6,802
| -2% | -$294K |
|
436
Renasant Corp
RNST
$4.01B
| $14.9M | 0.02% |
460,224
-8,278
| -2% | -$276K |
|
437
Ocular Therapeutix
OCUL
$1.86B
| $14.7M | 0.02% |
2,972,606
+1,643,261
| +124% | +$16.3M |
|
438
Rocket Pharmaceuticals
RCKT
$348M
| $14.5M | 0.02% |
487,097
-388
| -0.1% | -$13.6K |
|
439
CALL
Humana
HUM
$46.7B
| $14.4M | 0.02% |
+80,000
| New | +$14.2M |
|
440
Prothena Corp
PRTA
$458M
| $14.3M | 0.02% |
410,117
-578
| -0.1% | -$25.2K |
|
441
Heartland Express
HTLD
$1.11B
| $13.9M | 0.02% |
800,105
-264,314
| -25% | -$4.71M |
|
442
Freeport-McMoran
FCX
$90B
| $13.8M | 0.02% |
1,242,609
-42,848
| -3% | -$475K |
|
|
BPL
443
DELISTED
Buckeye Partners, L.P.
BPL
| $13.7M | 0.02% |
195,411
-23,122
| -11% | -$1.62M |
|
|
RDC
444
DELISTED
Rowan Companies Plc
RDC
| $13.7M | 0.02% |
776,095
-29,560
| -4% | -$512K |
|
|
ETP
445
DELISTED
Energy Transfer Partners, L.P.
ETP
| $13.7M | 0.02% |
475,471
+54,466
| +13% | +$1.5M |
|
446
HDFC Bank
HDB
$119B
| $13.6M | 0.01% |
821,212
-6,092
| -0.7% | -$97.1K |
|
|
SAGE
447
DELISTED
Sage Therapeutics
SAGE
| $13.1M | 0.01% |
433,411
+1,866
| +0.4% | +$62.2K |
|
448
ProQR Therapeutics
PRQR
$243M
| $12.9M | 0.01% |
2,672,377
-2,467
| -0.1% | -$12.7K |
|
|
TSRO
449
PUT
DELISTED
TESARO, Inc.
TSRO
| $12.9M | 0.01% |
+153,500
| New | +$6.84M |
|
|
EEP
450
DELISTED
Enbridge Energy Partners
EEP
| $12.8M | 0.01% |
553,825
+48,129
| +10% | +$1.02M |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $4.67B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.